Methods and data needs to assess health impacts of chemicals in industrial contaminated sites.

Metodi e dati necessari per la valutazione di impatto sulla salute delle sostanze chimiche nei siti industriali contaminati.

Journal

Epidemiologia e prevenzione
ISSN: 1120-9763
Titre abrégé: Epidemiol Prev
Pays: Italy
ID NLM: 8902507

Informations de publication

Date de publication:
Historique:
entrez: 26 10 2019
pubmed: 28 10 2019
medline: 30 4 2020
Statut: ppublish

Résumé

human exposure to mixtures of chemicals of toxicological interest, typically found in industrial contaminated sites (ICSs), has been associated with a broad range of different health outcomes. Deprived population groups endure most of the burden of disease and premature death associated to the exposure to those pollutants. Characterising the impacts on health of an ICS is a challenging process. Currently the two main methodological approaches used are Human Health Risk Assessment (HHRA) and Environmental Epidemiological (EE) studies. review existing guidance and scientific evidence for HHRA and EE studies applied to contaminated sites that orientate in selecting the most suitable methodological approach for characterising health impacts in ICSs according to the site characteristics, and the availability of environmental, health and sociodemographic data. HHRA has evolved into a more holistic approach, placing more emphasis in planning, community involvement and adapting the dimension of the assessment to the problem formulation and to the availability of resources. Many different HHRA guidelines for contaminated sites has been published worldwide, and although they share a similar framework, the scientific evidence used for deriving reference values and the variet of policy options can result in a wide variability of health risk estimates. This paper condenses different options with the recommendations to use those tools, default values for environmental and exposure levels and toxicological reference values that most suit to the population and characteristics of the ICSs under evaluation. the suitability to use one or another approach to assess the impact of ICSs on health depends on the availability of data, cost-benefit aspects and the kind of problem that needs to be answered. Risk assessment based on toxicological data can be very rapid and cheap, providing direct information when the intervention to protect the health of population is urgent and no suitable dose-response functions are available from epidemiological studies. Conducting EE studies provide a deeper insight into the problem of the exposure to industrial pollutants that do not require extrapolation from data obtained from toxicological studies or other population, addressing the community concern's more directly. Complementing the results obtained from different approaches, including those from public health surveillance systems, might provide an efficient and complete response to the impact of ICSs.

Sections du résumé

BACKGROUND BACKGROUND
human exposure to mixtures of chemicals of toxicological interest, typically found in industrial contaminated sites (ICSs), has been associated with a broad range of different health outcomes. Deprived population groups endure most of the burden of disease and premature death associated to the exposure to those pollutants. Characterising the impacts on health of an ICS is a challenging process. Currently the two main methodological approaches used are Human Health Risk Assessment (HHRA) and Environmental Epidemiological (EE) studies.
OBJECTIVES OBJECTIVE
review existing guidance and scientific evidence for HHRA and EE studies applied to contaminated sites that orientate in selecting the most suitable methodological approach for characterising health impacts in ICSs according to the site characteristics, and the availability of environmental, health and sociodemographic data.
RESULTS RESULTS
HHRA has evolved into a more holistic approach, placing more emphasis in planning, community involvement and adapting the dimension of the assessment to the problem formulation and to the availability of resources. Many different HHRA guidelines for contaminated sites has been published worldwide, and although they share a similar framework, the scientific evidence used for deriving reference values and the variet of policy options can result in a wide variability of health risk estimates. This paper condenses different options with the recommendations to use those tools, default values for environmental and exposure levels and toxicological reference values that most suit to the population and characteristics of the ICSs under evaluation.
CONCLUSIONS CONCLUSIONS
the suitability to use one or another approach to assess the impact of ICSs on health depends on the availability of data, cost-benefit aspects and the kind of problem that needs to be answered. Risk assessment based on toxicological data can be very rapid and cheap, providing direct information when the intervention to protect the health of population is urgent and no suitable dose-response functions are available from epidemiological studies. Conducting EE studies provide a deeper insight into the problem of the exposure to industrial pollutants that do not require extrapolation from data obtained from toxicological studies or other population, addressing the community concern's more directly. Complementing the results obtained from different approaches, including those from public health surveillance systems, might provide an efficient and complete response to the impact of ICSs.

Identifiants

pubmed: 31650778
doi: 10.19191/EP19.4.A01.068
pii: 4532
doi:

Substances chimiques

Environmental Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-237

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Auteurs

Piedad Martin-Olmedo (P)

Escuela Andaluza de Salud Pública, Granada (Spain); piedad.martin.easp@juntadeandalucia.es.
Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada (Spain).

Andrea Ranzi (A)

Centre for Environmental Health and Prevention, Regional Agency for Prevention, Environment and Energy of Emilia-Romagna, Modena (Italy).

Michele Santoro (M)

Institute of Clinical Physiology, National Research Council, Pisa (Italy).

Sarah Dack (S)

Public Health England (UK).

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Basel (Switzerland).
University of Basel, Basel (Switzerland).

Marco Martuzzi (M)

World Health Organization Regional Office for Europe, Bonn (Germany).

Eugenia Dogliotti (E)

Department of Environment and Health, Istituto Superiore di Sanità, Rome (Italy).

Gerard Hoek (G)

Institute for Risk Assessment Sciences, Utrecht University (Netherlands).

Jelena Tomasova (J)

Health Board (Estonia).

Mirjana Dimovska (M)

Institute of Public Health (Republic of North Macedonia).

Ivano Iavarone (I)

Department of Environment and Health, Istituto Superiore di Sanità, Rome (Italy).
WHO Collaborating Centre for environmental Health in contaminated sites, Rome (Italy).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH